RNM, an immunomodulatory therapeutic component, is used to encode oncological mutation-activated peptides.

摘要

This description describes an immunoregulatory therapeutic component of RNM, which encrypts an oncology mutation-activating peptide and a RNM encoding a polypeptide to enhance the immune response to oncology mutation-activating peptide, for example, An RNA encoding immunosuppressive agents The description also describes methods of using these methods, such as stimulating cancer immune response.